PMID: 6336951Jan 1, 1983Paper

Comparison between antifibrinolytic and antiprostaglandin treatment in the reduction of increased menstrual blood loss in women with intrauterine contraceptive devices

British Journal of Obstetrics and Gynaecology
O Ylikorkala, L Viinikka

Abstract

The effects of a fibrinolysis inhibitor (tranexamic acid, TA) and prostaglandin synthesis inhibitor (diclofenac sodium, DS) were compared in the reduction of excessive menstrual blood loss in 19 women with an intrauterine contraceptive device (IUCD). These women (mean blood loss before treatment to 135.1 +/- 18.9 SE ml, range 70-294 ml) were treated in random order with TA (1.5 g three times daily for 5 days starting on the first day of menstruation for two periods), and with DS (50 mg three times on the first day followed by 25 mg three times daily for 4 days, for two periods), or with placebo (one period) in a double-blind trial. The placebo treatment did not change menstrual blood loss (128.3 +/- 15.6 ml). The TA treatment decreased blood loss to 59.4 +/- 7.7 ml (P less than 0.001) and the DS treatment to 102.1 +/- 13.6 ml (P less than 0.01). Neither treatment abolished pelvic discomfort during menstruation or shortened its duration. Various side-effects were noted by 12 women during 19 TA treatments and by five women during six DS treatments. Thus, while TA is generally far more effective, DS gave pronounced decreases in menstrual bleeding in some women and had less frequent side-effects.

References

Apr 1, 1978·American Journal of Obstetrics and Gynecology·O Ylikorkala, M Y Dawood
Feb 1, 1976·British Journal of Obstetrics and Gynaecology·J BonnarM J Allington
Nov 1, 1977·The Journal of School Health·T W O'Rourke, J P Allegrante
Jan 1, 1978·British Journal of Obstetrics and Gynaecology·J GuillebaudA C Turnbull
Nov 1, 1979·Prostaglandins·M H Abel, R W Kelly
Oct 4, 1975·British Medical Journal·J M Kasonde, J Bonnar
Apr 1, 1976·British Journal of Obstetrics and Gynaecology·J M Kasonde, J Bonnar
May 1, 1976·British Journal of Obstetrics and Gynaecology·E A WillmanS G Clayton
Jul 1, 1971·American Journal of Obstetrics and Gynecology·L NILSSON, G Rybo
Jan 1, 1966·Acta Obstetricia Et Gynecologica Scandinavica·L HALLBERGG Rybo
May 1, 1980·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·P J HaynesA C Turnbull
Mar 14, 1981·Lancet·G RyboK G Nygren
Apr 1, 1981·British Journal of Obstetrics and Gynaecology·S K SmithD T Baird
Jan 1, 1964·Scandinavian Journal of Clinical and Laboratory Investigation·L HALLBERG, L NILSSON

Citations

Feb 24, 2001·BJOG : an International Journal of Obstetrics and Gynaecology·A StewartW Phillips
Jan 1, 1995·International Journal of Technology Assessment in Health Care·A CoulterM C Rees
Mar 1, 1995·British Journal of Pharmacology·T J Gelety, G Chaudhuri
Jun 27, 2003·Drugs·Keri Wellington, Antona J Wagstaff
Mar 21, 2012·Journal of Women's Health·Ken MuseTammie L Adomako
Jan 11, 2012·Acta Obstetricia Et Gynecologica Scandinavica·Becky Naoulou, Ming C Tsai
Apr 1, 1996·Baillière's Clinical Obstetrics and Gynaecology·V Odlind
Dec 1, 1992·Baillière's Clinical Obstetrics and Gynaecology·I S Fraser
Nov 25, 2015·Obstetrics and Gynecology Clinics of North America·EmmaKate Friedlander, Bliss Kaneshiro
Jul 20, 2011·Expert Opinion on Pharmacotherapy·Mary Ann Lumsden, Lilantha Wedisinghe
Feb 24, 2001·BJOG : an International Journal of Obstetrics and Gynaecology·C Kremer, S Duffy
Apr 16, 2018·The Cochrane Database of Systematic Reviews·Alison C Bryant-SmithMartha Hickey
Jan 5, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·Y L OngE E Mayne
Sep 25, 2018·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Ahmed AlanwarE Eltaieb
Feb 1, 1991·The Australian & New Zealand Journal of Obstetrics & Gynaecology·I S Fraser, G McCarron
Mar 10, 2004·The Journal of Family Planning and Reproductive Health Care·Gillian PenneyFaculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit
Sep 1, 1994·Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception·J F PanQ H Yan
Mar 1, 1986·British Journal of Obstetrics and Gynaecology·L Mäkäräinen, O Ylikorkala
Jun 16, 1990·BMJ : British Medical Journal·A L Magos
Oct 21, 2006·The Cochrane Database of Systematic Reviews·D A GrimesK F Schulz
Aug 3, 1985·British Medical Journal·A D Noble
Oct 18, 2000·The Cochrane Database of Systematic Reviews·A LethabyI Cooke
Jul 1, 1994·British Journal of Obstetrics and Gynaecology·R W Shaw
Aug 6, 1995·Quality in Health Care : QHC·A CoulterT A Sheldon
May 20, 2003·Acta Obstetricia Et Gynecologica Scandinavica·M K Oehler, M C P Rees
Jun 18, 2010·The Cochrane Database of Systematic Reviews·G Justus HofmeyrTheresa A Lawrie
Nov 4, 1996·The Medical Journal of Australia·C E Wood

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Separation Anxiety

Separation anxiety is a type of anxiety disorder that involves excessive distress and anxiety with separation. This may include separation from places or people to which they have a strong emotional connection with. It often affects children more than adults. Here is the latest research on separation anxiety.

KIF1A Associated Neurological Disorder

KIF1A associated neurological disorder (KAND) is a rare neurodegenerative condition caused by mutations in the KIF1A gene. KAND may present with a wide range and severity of symptoms including stiff or weak leg muscles, low muscle tone, a lack of muscle coordination and balance, and intellectual disability. Find the latest research on KAND here.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.